Literature DB >> 25068842

Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.

Dongying Chen1, Shiwen Yuan, Xiangni Wu, Hao Li, Qian Qiu, Zhongping Zhan, Yujin Ye, Fan Lian, Liuqin Liang, Hanshi Xu, Xiuyan Yang.   

Abstract

OBJECTIVES: We aimed to explore the incidence of malignancy in dermatomyositis and assess the potential risk factors of occurrence of malignancy in DM from southern China.
METHODS: A retrospective cohort study of patients admitted in the 1st affiliated university hospital between 2003 and 2012 was performed. Demographic information, clinical symptoms, laboratory findings, medications were documented. The endpoint of the study was defined as occurrence of malignancy or death.
RESULTS: For this approximately 10-year retrospective study, 60 out of 246 dermatomyositis patients developed malignancies with the overall incidence of 24.4%. Nasopharyngeal carcinoma (NPC) and ovarian carcinoma were the most common malignant disease, accounting for 35% (21/60) and 15% (9/60) of malignancies, respectively. Lung and colon were followed as the third most common carcinoma (5 out of 60, 8.3%). Among these 60 patients with malignancies, 39 (65.0%, 39/60) cases occurred within 1 year after DM diagnosis. Subsequently, malignancies were detected in 13 (21.7%, 13/60) patients during the second year and 8 (13.3%, 8/60) during the third year. One patient developed cancer at the 35th month after DM as the latest. The logistic regression multivariate analysis indicated that male gender [odds ratio (OR) = 3.76, 95% confidence interval (CI ) 1.86~7.61, p<0.01], dysphagia (OR= 2.21, 95%CI 1.10~4.48, p=0.03) and elevated erythrocyte sedimentation rate (ESR) (OR= 2.37, 95% CI 1.18~4.75, p=0.02) were risk factors for the occurrence of malignancies, while interstitial lung disease (ILD) acted as a protective factor (OR=0.13, 95%CI 0.06~0.28, p<0.01).
CONCLUSIONS: It was necessary to carry out routine malignancy screening for Chinese DM patients due to its high incidence. Nasopharyngeal carcinoma and ovarian cancer were the most common malignant disease. The risk of malignancy was highest in the first year after DM diagnosis and reduced thereafter. Extensive work-ups for malignancy screening should be carried out at the first year. Male gender, dysphagia and elevated ESR were risk factors for occurrence of malignancy. The presence of ILD could diminish the risk of coexisting of malignancy.

Entities:  

Mesh:

Year:  2014        PMID: 25068842

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

1.  Case report: dermatomyositis associated with lung cancer with heterogeneous morphology.

Authors:  Yin-Yin Qin; Cheng-Zhi Zhou; Zheng Zhu; Wei-Jie Guan; Xin-Qing Lin; Chun-Li Liu; Yu-Ming Zhou; Hua Wu; Ying-Ying Gu; De-Hua Zhang; Ming Ou-Yang; Nan-Shan Zhong; Shi-Yue Li
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 2.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 3.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

4.  Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.

Authors:  Jin Kyun Park; Ji Ae Yang; Eun Young Ahn; Sung Hae Chang; Yeong Wook Song; Jeffrey R Curtis; Eun Bong Lee
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

5.  Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature.

Authors:  Le Zhang; Chenghua Zhang; Zhaoying Yang; Miao He; Lijuan Zhang; Shereen Ezzat; Xi Liang
Journal:  Onco Targets Ther       Date:  2017-11-14       Impact factor: 4.147

6.  An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis.

Authors:  Zhen-Guo Huang; Bao-Xiang Gao; He Chen; Min-Xing Yang; Xiao-Liang Chen; Ran Yan; Xin Lu; Kai-Ning Shi; Queenie Chan; Guo-Chun Wang
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

7.  Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.

Authors:  Chanyuan Wu; Qian Wang; Linrong He; Enhao Yang; Xiaofeng Zeng
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

8.  A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy.

Authors:  Wakako Daido; Masahiro Yamasaki; Yuka Morio; Kunihiko Funaishi; Sayaka Ishiyama; Naoko Deguchi; Masaya Taniwaki; Nobuyuki Ohashi; Noboru Hattori
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

9.  Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China.

Authors:  Ying Liu; Lulu Xu; Hongliang Wu; Na Zhao; Yanchun Tang; Xiaoping Li; Ying Liang
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

10.  Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.

Authors:  Lili Chang; Lina Zhang; Haiquan Jia; Zhiyong Nie; Lei Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.